Browse by Medical Category
Accepting New Patients
Go To Programs
Go To Specialties
MassGeneral Hospital for Children
Go To Specialties
Dicken S. C. Ko, BSc, MD, FRCSC, FACS, is Director of Regional Urology for Massachusetts General Hospital, overseeing affiliates sites, integrating clinical practices, sharing academic and community practices, developing lean practice programs, and exploring regional growth opportunities. Before joining Department of Urology full-time in 2012, Dr. Ko worked at Massachusetts General Hospital as a multi-organ transplant surgeon in the Departments of Surgery and Pediatric Surgery where he was Surgical Director of the Renal Transplant Program that oversaw the growth and quality outcomes of the center for eight years. Dr. Ko earned a Bachelor’s in Physiology/Biology from the University of British Columbia, a medical degree from Queen’s University, and received training in hospital leadership from Massachusetts General Hospital. He completed his residency in urology at the University of British Columbia and fellowship in transplantation at Massachusetts General Hospital, Boston. Dr. Ko served on national committees and boards including the UNOS kidney and pancreas committee and continued to serve on Harvard Medical School committees as well as American Board of Urology where he is an examiner. His scholarly activities focus on tolerance models of transplantation, urologic outcomes research, and economics of transplantation. Dr. Ko has over 75 publications in peer-reviewed journals including the New England Journal of Medicine, Journal of Urology, Transplantation, and American Journal of Transplantation. He was the 28th President of the Urological Society for Transplantation and Renal Surgery.
In addition to providing administrative oversight to two major programs at MGH, clinical care, and teaching, I have been conducting clinical research on transplant surgery, vascular reconstruction, tolerance induction without immunosuppression, and urologic voiding dysfunction. I have received funding from grants (Juvenile Diabetes Research Foundation) as a Principle Investigator that aimed to determine the feasibility of induction of islet cell tolerance in the cure of diabetes. I currently have under review a grant that proposes to study the novel approach to genitourinary reconstruction with vascularized composite grafts in collaborations with Plastic Surgery at MGH.
I have received the following awards in recognition of my excellence in research: a) Investigator Award in Dialysis International for outstanding peritoneal dialysis outcomes; b) Certificate of Merit at the American Roentgen Ray Society for formulating 3D CT technology in living donor kidney imaging; c) Outstanding Contributions to Endourology at the Chinese Urological Association 2007, d) Poster of Distinction at the American Transplant Congress 2008 for excellence in organ allocation and health economics; e) Martin Prize in Research 2008 for innovations in transplantation tolerance; and f) American Urological Association 2014 Outstanding Poster for influence of phytoestrogens in female voiding dysfunction. I have and continue to serve as ad hoc reviewer on editorial boards including NEJM, Am J Trans, Ann of Surg, J Urol, Transpl. I was Editor for Current Opinions in Organ Transplantation for pediatric organ transplantation; National Blood Service grant reviewer in the U.K.; and a four-year term as Member of the Chinese Medical Journal International Editorial Board.
1. Kawai T, Sogawa H, Koulmanda M, Smith RN, O’Neill JJ, Wee SL, Boskovic S, Sykes M, Colvin RB, Sachs DH, Auchincloss H Jr, Cosimi AB, Ko DSC. Long-term islet allograft function in the absence of chronic immunosuppression: a case report of a nonhuman primate previously made tolerant to a renal allograft from the same donor. Transplantation. 2001; 72(2):351-4.
2. Kawai T, Cosimi AB, Spitzer TR, Tolkoff-Rubin N, Suthanthiran M, Saidman SL, Shaffer J, Preffer FI, Ding R, Sharma V, Fishman JA, Dey B, Ko DSC, Hertl M, Goes NB, Wong W, Williams WW, Colvin RB, Sykes M, Sachs DH. HLA-mismatched renal transplantation without maintenance immunosuppression. New England Journal of Medicine. 2008; 358(4):353-61.
3. Saidi RF, Elias N, Kawai T, Hertl M, Farrell M-L, Goes N, Wong W, Hartono C, Fishman JA, Kotton CN, Tolkoff-Rubin N, Delmonico FL, Cosimi AB, Ko DSC. Outcome of kidney transplantation using expanded criteria donors and donation after cardiac death kidney: realities and costs. American Journal of Transplantation. 2007; 7(2):2669-74.
4. Saidi RF, Kawai T, Kennealey PT, Tsouflas G, Elias N, Hertl M, Cosimi AB, Ko DSC. Living donor kidney transplantation with multiple arteries: recent increase in modern era of laparoscopic donor nephrectomy. Archives of Surg. 2009; 144(5):472-5.
5. Kreydin E, Ko DSC. Immediate Renal Transplantation after Radical Prostatectomy for Low-Risk Prostate Cancer. Clinical Transplantation 27, 162 (2013)
6. Saidi RF, Razavi M, Cosimi AB, Ko DSC. Competition in Liver Transplantation: Helpful or Harmful? Liver Transplantation, Feb 2015, 21(2): 145-150.
John Marzelli and Esperanza Yoblonsky were suffering from IgA nephropathy and both needed a new kidney; they found the answer in the Mass General Transplant Center's internal exchange program.
Chain 124. That's the name of a record-breaking kidney transplant chain.
Toddler Andrew Johnson is thriving since receiving his mother's kidney in a transplant at MassGeneral Hospital for Children.
What to expect during admission for ambulatory procedures with short recovery time, allowing discharge that day.
What to expect during admission for a prostatectomy procedure. A prostatectomy is a surgical procedure to remove the prostate gland.
What to expect during admission for a nephrectomy procedure. A nephrectomy is a surgical procedure to remove all or part of the kidney. Surgery may involve one or both kidneys.
What to expect during admission for a cystectomy procedure. A cystectomy is a surgical procedure to removal all or part of the urinary bladder.
Back to Top